537 related articles for article (PubMed ID: 8415756)
1. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.
Schmechel DE; Saunders AM; Strittmatter WJ; Crain BJ; Hulette CM; Joo SH; Pericak-Vance MA; Goldgaber D; Roses AD
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9649-53. PubMed ID: 8415756
[TBL] [Abstract][Full Text] [Related]
2. The APOE4 allele shows opposite sex bias in microbleeds and Alzheimer's disease of humans and mice.
Cacciottolo M; Christensen A; Moser A; Liu J; Pike CJ; Smith C; LaDu MJ; Sullivan PM; Morgan TE; Dolzhenko E; Charidimou A; Wahlund LO; Wiberg MK; Shams S; Chiang GC; ; Finch CE
Neurobiol Aging; 2016 Jan; 37():47-57. PubMed ID: 26686669
[TBL] [Abstract][Full Text] [Related]
3. Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease.
Mann DM; Pickering-Brown SM; Takeuchi A; Iwatsubo T;
Am J Pathol; 2001 Jun; 158(6):2165-75. PubMed ID: 11395394
[TBL] [Abstract][Full Text] [Related]
4. The role of APOE polymorphisms in late-onset dementias.
Corder EH; Lannfelt L; Bogdanovic N; Fratiglioni L; Mori H
Cell Mol Life Sci; 1998 Sep; 54(9):928-34. PubMed ID: 9791536
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E and Sex Bias in Cerebrovascular Aging of Men and Mice.
Finch CE; Shams S
Trends Neurosci; 2016 Sep; 39(9):625-637. PubMed ID: 27546867
[TBL] [Abstract][Full Text] [Related]
6. Novel APOE Mutation in a Moroccan Subject Suffering from Alzheimer Disease: A Case Study and Exploration of Pathogenic Implication.
Razouqi Y; El Bouchikhi I; El-Abid H; Baammi S; Nedbour A; Touhami Ahami AO; El Allali A; Bouguenouch L
Alzheimer Dis Assoc Disord; 2023 Oct-Dec 01; 37(4):370-372. PubMed ID: 38015425
[TBL] [Abstract][Full Text] [Related]
7. Linking Late-Onset Epilepsy With Alzheimer Disease: Insights From Plasma Amyloid Measurements.
Lam AD
Neurology; 2023 Sep; 101(13):551-552. PubMed ID: 37541840
[No Abstract] [Full Text] [Related]
8. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.
Farrer LA; Cupples LA; Haines JL; Hyman B; Kukull WA; Mayeux R; Myers RH; Pericak-Vance MA; Risch N; van Duijn CM
JAMA; 1997 Oct 22-29; 278(16):1349-56. PubMed ID: 9343467
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
Strittmatter WJ; Saunders AM; Schmechel D; Pericak-Vance M; Enghild J; Salvesen GS; Roses AD
Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1977-81. PubMed ID: 8446617
[TBL] [Abstract][Full Text] [Related]
10. Linking peripheral atherosclerosis to blood-brain barrier disruption: elucidating its role as a manifestation of cerebral small vessel disease in vascular cognitive impairment.
Nyúl-Tóth Á; Patai R; Csiszar A; Ungvari A; Gulej R; Mukli P; Yabluchanskiy A; Benyo Z; Sotonyi P; Prodan CI; Liotta EM; Toth P; Elahi F; Barsi P; Maurovich-Horvat P; Sorond FA; Tarantini S; Ungvari Z
Geroscience; 2024 Jun; ():. PubMed ID: 38831182
[TBL] [Abstract][Full Text] [Related]
11. Co-aggregation with Apolipoprotein E modulates the function of Amyloid-β in Alzheimer's disease.
Xia Z; Prescott EE; Urbanek A; Wareing HE; King MC; Olerinyova A; Dakin H; Leah T; Barnes KA; Matuszyk MM; Dimou E; Hidari E; Zhang YP; Lam JYL; Danial JSH; Strickland MR; Jiang H; Thornton P; Crowther DC; Ohtonen S; Gómez-Budia M; Bell SM; Ferraiuolo L; Mortiboys H; Higginbottom A; Wharton SB; Holtzman DM; Malm T; Ranasinghe RT; Klenerman D; De S
Nat Commun; 2024 Jun; 15(1):4695. PubMed ID: 38824138
[TBL] [Abstract][Full Text] [Related]
12. The influence of APOE
Thierry M; Ponce J; Martà-Ariza M; Askenazi M; Faustin A; Leitner D; Pires G; Kanshin E; Drummond E; Ueberheide B; Wisniewski T
Acta Neuropathol; 2024 May; 147(1):91. PubMed ID: 38772917
[TBL] [Abstract][Full Text] [Related]
13. Differences of individual gray matter networks between MCI patients who converted to AD within 3 Years and nonconverters.
Zhou B; Zhao Y; Wu X
Heliyon; 2024 Apr; 10(7):e28874. PubMed ID: 38623255
[TBL] [Abstract][Full Text] [Related]
14. Limbic-predominant age-related TDP-43 encephalopathy (LATE-NC): Co-pathologies and genetic risk factors provide clues about pathogenesis.
Nelson PT; Fardo DW; Wu X; Aung KZ; Cykowski MD; Katsumata Y
J Neuropathol Exp Neurol; 2024 May; 83(6):396-415. PubMed ID: 38613823
[TBL] [Abstract][Full Text] [Related]
15. Normal-Tension Glaucoma and Potential Clinical Links to Alzheimer's Disease.
Ho K; Bodi NE; Sharma TP
J Clin Med; 2024 Mar; 13(7):. PubMed ID: 38610712
[TBL] [Abstract][Full Text] [Related]
16. Imaging Amyloid-β Membrane Interactions: Ion-Channel Pores and Lipid-Bilayer Permeability in Alzheimer's Disease.
Viles JH
Angew Chem Weinheim Bergstr Ger; 2023 Jun; 135(25):e202215785. PubMed ID: 38515735
[TBL] [Abstract][Full Text] [Related]
17. pH Dependence of Amyloid-β Fibril Assembly Kinetics: Unravelling the Microscopic Molecular Processes.
Tian Y; Viles JH
Angew Chem Weinheim Bergstr Ger; 2022 Nov; 134(48):e202210675. PubMed ID: 38504922
[TBL] [Abstract][Full Text] [Related]
18. The Single Toxin Origin of Alzheimer's Disease and Other Neurodegenerative Disorders Enables Targeted Approach to Treatment and Prevention.
Tolar M; Hey JA; Power A; Abushakra S
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473975
[TBL] [Abstract][Full Text] [Related]
19. APOE4 genotype and aging impair injury-induced microglial behavior in brain slices, including toward Aβ, through P2RY12.
Sepulveda J; Kim JY; Binder J; Vicini S; Rebeck GW
Mol Neurodegener; 2024 Mar; 19(1):24. PubMed ID: 38468308
[TBL] [Abstract][Full Text] [Related]
20. Genetic Risk for Alzheimer's Disease Alters Perceived Executive Dysfunction in Cognitively Healthy Middle-Aged and Older Adults.
Evans SA; Paitel ER; Bhasin R; Nielson KA
J Alzheimers Dis Rep; 2024; 8(1):267-279. PubMed ID: 38405345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
